**Strong Growth and Bookings Outlook**: Axon has reported a 32% year-over-year increase in revenue for Q3 2024, marking its 11th consecutive quarter of growth above 25%. The company closed over $1 billion in record bookings, positioning itself for a strong Q4, which historically has been the strongest quarter for bookings.
**AI Era Strategy and Product Development**: The company is pivoting towards a new AI Era plan, with products like Draft One as the central offering. Interest in AI tools is growing rapidly and is expected to drive future revenue. The new AI bundle, priced around $199 a month, is anticipated to significantly enhance overall software ARR, which is already at $885 million (up 36% YOY).
**TASER Business Performance**: TASER products, particularly the TASER 10, have shown robust demand, achieving a 36% year-over-year revenue growth. Axon sees significant opportunity for further international expansion, especially where there is lower penetration of handguns and the potential for TASERs to be primary self-defense weapons.